Recent

% | $
Quotes you view appear here for quick access.

Compugen Ltd. (CGEN) Message Board

sydbiz2000 3 posts  |  Last Activity: Jan 15, 2016 2:43 PM Member since: May 14, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Playing between $7.50 and $5 strike prices.....little risk, with little volume and only possibilities makes this a perfect stock for these guys to manipulate up and down....
    Lets hope news and better possibilities gets us back on track.

  • Death by a thousand cuts...Hopefully just until year end.
    any thoughts?

  • UBS: The next big investment theme could be a cancer treatment

    . Business Insider
    By Lucinda Shen
    November 25, 2015 9:22 AM


    One of the most promising long-term investment opportunities could be a cancer treatment known as immunotherapy, according to UBS's global chief investment officer.

    "This emerging science offers the potential for attractive returns," said Mark Haefele, who oversees the investment policy and strategy for $2 trillion.

    Immunotherapy is an increasingly popular cancer treatment that, roughly put, trains the body's immune system to aggressively attack cancerous cells that wouldn't ordinarily be recognized as threatening.

    The immune system often overlooks cancer cells, but multiple types of immunotherapy have been developed in the past decade to address that.

    Some treatments create proteins that bind to cancerous cells, marking them for the immune system. Another treatment involves extracting the white blood cells most active against tumors in the patient's body, and genetically modifying the cells to specifically attack cancerous ones.

    'A hope they couldn't have fathomed'

    The treatment came into focus just a few years ago, when clinical trials started showing promising results. In a 2013 test by Bristol-Myers Squibb, 22% of the 1,800 advanced melanoma patients treated with immunotherapy Yervoy were alive three years later.

    "For physicians accustomed to losing every patient with advanced disease, the numbers bring a hope they couldn't have fathomed a few years ago," wrote Jennifer Couzin-Frankel for Science Magazine, after naming cancer immunotherapy as the breakthrough of 2013.

    "The market for cancer treatments is expanding rapidly as populations age, and gover

CGEN
4.69-0.05(-1.05%)Feb 5 4:00 PMEST